US OptionsDetailed Quotes

SAVA241018P23000

Watchlist
  • 0.02
  • -0.02-50.00%
15min DelayTrading Oct 17 11:53 ET
0.02High0.02Low

Cassava Sciences Stock Discussion

Sign in to post a comment
    $Cassava Sciences (SAVA.US)$ I feel strongly that this is gonna pop any week, before phase 3 results are released. Perhaps when Cassava shows the interview with the family of patients who are in the phase 3 study
    So far 24.60 is holding as support. Needs to get back over the POC at 27.31 to move up. If 24.60 fails watch for another leg down.
    Larger Image: tradingview.com...
    $Cassava Sciences (SAVA.US)$  
    $SAVA Support / Resistance Levels
    $Cassava Sciences (SAVA.US)$ 8K of Completed Rethink Trial, Why there was an SEC Settlement and results any day now. After This, there is no way that you can continue to short legally after you've done this 3+ years every day with naked shares. SEC, you need to do your job and keep the market fair since you received your money that you felt you needed before this moved forward. You cannot allow market manipulation by shorts to continue as though you are complicit with them. SAVA "I welcome the op...
    Picture
    $Cassava Sciences (SAVA.US)$This is full corruption by the SEC, shorts and market makers. Not only did they charge SAVA 40 Million and accusations for misleading investors but yet they do nothing on a daily basis and let the shorts  short the stock price with unlimited shares when there are no more shares left to short  FTDs.  They are really corrupt, cheating and stealing and getting away with it.  This is supposed to be a fair market. Shorting is legal but this is arrogant cheating and there wi...
    $Cassava Sciences (SAVA.US)$ It is unethical and inexcusable what the shorts have done by delaying trials, trying to stop with citizens petition , writing FUD articles and manipulating stock price daily for 3+ years. They failed and must pay for their consequences of the lives they have disrupted from getting a Breakthrough treatment for AD. FDA has always been on SAVÀs side and  seen the good effects of treating/repairing misfolded protein. Cassava Sciences (NASDAQ:SAVA - Get Free Report) was up...
    Picture
    $Cassava Sciences (SAVA.US)$ This Open Letter is definitely showing that SAVA is about treating patients with AD and debunks all the crap the shorts have done for 3+ years.  ’I am happy to inform you that our ReTHINK Phase 3 clinical trial recently completed its last patient, last visit. All patients have completed dosing, and all that remains is to collect and analyze the data. For a company our size, this is a remarkable achievement. This study enrolled 804 patients at 77 sites in the US, Puert...
    Picture
    $Cassava Sciences (SAVA.US)$ This is also why the SEC has Corruption: Short interest is not reported frequently. Broker dealers “locate” instead of borrow or they use counterfeit shares. There’s no buy-in. Buy-ins were allowed but not required. Reg SHO, SHO for short selling. The hedge funds and big brokers who had been or would be shown to be illegally shorting all lobbied against it.
    To protect short sellers and avoid Reg SHO, dealers went ex-clearing. They either cleared internally or with a c...
    Picture
    1
    $Cassava Sciences (SAVA.US)$ New Bullish Luysii Press Article giving full context of current state of SAVA: "Even if you assume that Lindsay ‘cherry picked’ the data, no one has data showing improvement in a subset of patients at nine months like this. The best the monoclonal antibody treatments of Alzheimer’s can offer is a slight lessening of the rate decline on average. Similar unprecedented improvement in a subset of cancer patients (not everyone) has led to an explosion of research on immune...
    Picture
    $Cassava Sciences (SAVA.US)$ Although The SEC has not taken action on SAVA stock price manipulation by shorts/ Hedge Funds algorithm trading but with enough research, data(Screenshot evidence) and the daily abuse for 4+ years, they will be forced to address it by being exposed to media outlets and investigators. The Market Manipulation is called “Marking the close” is a market abuse practice that involves buying or selling securities or derivatives contracts near the end of the trading day to man...
    Picture
    1

No comment yet